Health firm Fishawack has acquired US-based agency Dudnyk.
Healthcare communication firm Fishawack has UK offices in London, Oxford, Knutsford and Brighton, US offices in San Diego and Philadelphia, and a base in India.
It has moved for Philadelphia-based Dudnyk, an award-winning, full-service agency that specialises in “creating brand experiences that unite physicians and their patients”.
It focuses on rare disease, oncology and the emergence of breakthrough therapies in molecular medicine.
“By joining forces with Fishawack, Dudnyk will be able to offer clients an even stronger service offering, including expertise in additional verticals like scientific communications and medical education,” said Dudnyk president Christopher Tobias.
“We are also excited to further expand our global capabilities, both commercially and medically, for our clients who operate on a scale outside of the US.”
GP Bullhound acted as exclusive financial advisor to Dudnyk on the deal.
Oliver Schweitzer, executive director at GP Bullhound, commented: “Dudnyk combines strategic, scientific and highly creative capabilities to bring to market life-changing brands and serve clients in the biotech, pharmaceutical, and medical device industries.
“We are delighted to have advised Dudnyk and to have helped them find the ideal partner for the next phase of growth.”